Re: A look back in time . . .

[Guest guest]

I am sure it was corporate business ~ DSee what's free at AOL.com.

[Guest guest]

We would not be in the mess that we are now facing. I wonder how he was killed?? Was he killed, or did he die from natural causes? Our Lori told us that it was no accident....wonders me...love you...Lea

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~``````````

2/13/92 DCC017002423 Rep. Ted Weiss is calling for the U.S. Justice Department to conduct a criminal investigation into whether Dow Corning with held scientific data from the FDA about the safety of silicone breast implants Date: Tue, 5 Jun 2007 14:28:41 -0700

This report was given after the untimely death of the chairman, Congressman Ted Weiss of NY.

HOUSE OF REPRESENTATIVES FDA'S REGULATION OF SILICONE BREAST IMPLANTS A STAFF REPORT PREPARED by THE HUMAN RESOURCES AND INTERGOVERNMENTAL RELATIONS SUBCOMMITTEE OF THE COMMITTEE ON GOVERNMENT OPERATIONS DECEMBER 1992 Printed for the use of the Committee on Government Operations U.S. GOVERNMENT PRINTING OFFICE WASHINGTON: 1993 61-505 For sale by the U.S. Government Printing Office Superintendent of Documents, Congressional Sales Office, Washington, DC 20402 ISBN 0-16-039937-8

=====================================

DCC017002423 February 13, 1992 U.S. Rep. Ted Weiss (D., New York) is calling for the U.S. JusticeDepartment to conduct a criminal investigation into whether DowCorning misled women, doctors and the government about the safety ofsilicone breast implants and whether Dow Corning withheld scientificdata from the FDA. In responding to Rep. Weiss' request for an investigation, Kerm, Group Vice President, U. S. Operations, commented that thecompany believes it has advised physicians and the FDA of its researchresults as they were known and understood over the course of theproduct's availability. "Even so," said, "we will cooperatefully with the Justice Department if they choose to conduct aninvestigation." "In addition, we have retained Judge Bell to conduct aninternal investigation on every aspect of our involvement in breastimplants. We are committed to following Judge Bell's recommendationsand will make public the findings of his review," said. McKennon today

resigned as a member of the Board of Directors ofThe Dow Chemical Company. Commenting on his decision, McKennon saidthat he needs to devote his full attention to his new responsibilitiesat Dow Corning. Watch for articles on McKennon in several upcoming issues ofnational news magazines. NEWSWEEK, BUSINESS WEEK and TIME are allplanning to run stories and/or photos following interviews and photoshoots at the Dow Coning Center site on Wednesday. Today's Detroit Free Press has a front page article about in itsBusiness section. On television, CNN and WNEM-Channel 5 are expectedto broadcast interviews of during

the next few days. Several times each week, we will provide employees with summaries ofarticles and editorials that have been published in recent days. Thisis intended to give employees a sense of the media coveragesurrounding this issue and is not intended to be a reflection of allthat is being printed and broadcast. SOME WOMEN WANT THEIR BREAST IMPLANTS REMOVEDA growing number of breast implant patients, frightened by the FDAmoratorium, have asked to have their implants removed before anymedical complications arise. The FDA has recommended that women keeptheir implants unless they have experienced health problems. Dr. NirKossovsky, a UCLA pathologist, is trying to develop

asilicone-reactivity test which could be performed periodically onimplant patients to detect early immune system reactions. Article - THE ORANGE COUNTY REGISTER, Feb. 10,1992. NEW CEO CHANGES DOW CORNING'S PUBLIC POSTURE McKennon, the new chief executive officer of Dow Corning,expressed his concern for women in a statement which indicated asignificant shift in Dow Corning policy. The company's previousposition emphasized the safety of their implants. Mr. McKennonstressed the company's "overriding responsibility to the women whohave mammary implants." Two options under consideration at this timeinclude the establishment of a registry for breast implant patients,and a fund that would financially assist patients who wish to havetheir implants removed and who can't afford to do so. Mr. McKennonalso affirmed Dow Corning's commitment to cooperate completely withthe FDA. Article. - THE NEW YORK TIMES, Feb. 11, 1992. DOW CORNING REORGANIZES TOP MANAGEMENT AND

RELEASES DOCUMENTS McKennon, former executive vice president of Dow Chemical, takesover as chairman and chief executive officer of Dow Corning replacingLawrence who will serve as chief operating officer and president.This announcement, "perhaps by design, overshadowed the news arisingfrom Dow Corning documents that has led in large part to the currentFDA moratorium on implant sales."

Some of these documents raisedsafety questions about the SILASTIC II® implant. These documentsincluded letters written to Dow Corning by two physicians whoexpressed concern about thickness of the implant's shell and theconsistency of its silicone gel. Article - THE WALL STREET JOURNAL,Feb. 11, 1992 ATTORNEYS SPEAK OUT ABOUT IMPLANT SUITTwo lawyers defended the appropriateness of a jury's $7.3 milliondecision against a silicone breast implant manufacturer when theyspoke at a meeting sponsored by the Breast Implant InformationFoundation. The attorneys described the verdict as "a punishment forfraud and malice by the implant's manufacturer." Dr.

Minerquestioned the jury's ability to decide scientific issues andsuggested that these questions should be reviewed by the NationalInstitute of Health. Article - THE ORANGE COUNTY REGISTER, Feb. 8,1992 INTERNAL DOW CORNING MEMOS QUESTION BREAST IMPLANT SAFETYDow Corning has released an additional 800 pages of information,including inter-office memos, which suggest safety problems withsilicone breast implants. In one December 13, 1977, memo, a DowCorning employee reported that 52 of 400 implant procedures (done byfour physicians in Ohio and Michigan) had resulted in ruptures. DowCorning insists that the implants are safe and that these documentsare not scientific evidence.Article - THE DETROIT FREE PRESS, Feb. II, 1992 WOMEN SEEK OTHER OPTIONS FOR BREAST AUGMENTATION & RECONSTRUCTIONMany women are searching for alternatives to silicone gel implants inlight of the FDA moratorium. One option is the saline breast which isfirmer and does not feel as natural as the silicone implant. Anotheralternative is tissue-transfer surgery that creates a breast from"midriff bulge." The operation is expensive (approximately $14,000)and can result in abdominal weakness, but the reconstructed breastlooks and feels very natural.Article - THE DETROIT FREE PRESS, Feb. 11, 1992.

[Guest guest]

We were always suspicious, as he died so suddenly while in the middle of this.

Lynda

At 08:39 AM 6/6/2007, you wrote:

>We would not be in the mess that we are now

>facing. I wonder how he was killed?? Was he

>killed, or did he die from natural causes? Our

>Lori told us that it was no accident....wonders me...love you...Lea

>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~``````````

> 2/13/92 DCC017002423 Rep. Ted Weiss is

>calling for the U.S. Justice Department to

>conduct a criminal investigation into whether

>Dow Corning with held scientific data from the

>FDA about the safety of silicone breast implants

>Date: Tue, 5 Jun 2007 14:28:41 -0700

>

>This report was given after the untimely death

>of the chairman, Congressman Ted Weiss of NY.

>HOUSE OF REPRESENTATIVES FDA'S REGULATION OF

>SILICONE BREAST IMPLANTS A STAFF REPORT PREPARED

>by THE HUMAN RESOURCES AND INTERGOVERNMENTAL

>RELATIONS SUBCOMMITTEE OF THE COMMITTEE ON GOVERNMENT OPERATIONS DECEMBER 1992

>Printed for the use of the Committee on Government Operations

>U.S. GOVERNMENT PRINTING OFFICE WASHINGTON: 1993

>61-505

>For sale by the U.S. Government Printing Office

>Superintendent of Documents,

>Congressional Sales Office,

>Washington, DC 20402

>ISBN 0-16-039937-8

>

>=====================================

>

>DCC017002423

>

>February 13, 1992

>

>U.S. Rep. Ted Weiss (D., New York) is calling for the U.S. Justice

>Department to conduct a criminal investigation into whether Dow

>Corning misled women, doctors and the government about the safety of

>silicone breast implants and whether Dow Corning withheld scientific

>data from the FDA.

>

>In responding to Rep. Weiss' request for an investigation, Kerm

>, Group Vice President, U. S. Operations, commented that the

>company believes it has advised physicians and the FDA of its research

>results as they were known and understood over the course of the

>product's availability. " Even so, " said, " we will cooperate

>fully with the Justice Department if they choose to conduct an

>investigation. "

>

> " In addition, we have retained Judge Bell to conduct an

>internal investigation on every aspect of our

>involveme resigned as a member of the Board of Directors of

>The Dow Chemical Company. Commenting on his decision, McKennon said

>that he needs to devote his full attention to his new responsibilities

>at Dow Corning.

>

>Watch for articles on McKennon in several upcoming issues of

>national news magazines. NEWSWEEK, BUSINESS WEEK and TIME are all

>planning to run stories and/or photos following interviews and photo

>shoots at the Dow Coning Center site on Wednesday.

>

>Today's Detroit Free Press has a front page article about in its

>Business section. On television, CNN and WNEM-Channel 5 are expected

>to broadcast interviews of during

>

> the next few days.

>

>Several times each week, we will provide employees with summaries of

>articles and editorials that have been published in recent days. This

>is intended to give employees a sense of the media coverage

>surrounding this issue and is not intended to be a reflection of all

>that is being printed and broadcast.

>

>SOME WOMEN WANT THEIR BREAST IMPLANTS REMOVED

>A growing number of breast implant patients, frightened by the FDA

>moratorium, have asked to have their implants removed before any

>medical complications arise. The FDA has recommended that women keep

>their implants unless they have experienced health problems. Dr. Nir

>Kossovsky, a UCLA pathologist, is trying to develop

>

> a

>silicone-reactivity test which could be performed periodically on

>implant patients to detect early immune system reactions. Article -

>THE ORANGE COUNTY REGISTER, Feb. 10,1992.

>

>NEW CEO CHANGES DOW CORNING'S PUBLIC POSTURE

> McKennon, the new chief executive officer of Dow Corning,

>expressed his concern for women in a statement which indicated a

>significant shift in Dow Corning policy. The company's previous

>position emphasized the safety of their implants. Mr. McKennon

>stressed the company's " overriding responsibility to the women who

>have mammary implants. " Two options under consideration at this time

>include the establishment of a registry for breast implant patients,

>and a fund that would financially assist patients who wish to have

>their implants removed and who can't afford to do so. Mr. McKennon

>also affirmed Dow Corning's commitment to cooperate completely with

>the FDA. Article. - THE NEW YORK TIMES, Feb. 11, 1992.

>

>DOW CORNING REORGANIZES TOP MANAGEMENT AND

>

> RELEASES DOCUMENTS

> McKennon, former executive vice president of Dow Chemical, takes

>over as chairman and chief executive officer of Dow Corning replacing

>Lawrence who will serve as chief operating officer and president.

>This announcement, " perhaps by design, overshadowed the news arising

>from Dow Corning documents that has led in large part to the current

>FDA moratorium on implant sales. "

>

> Some of these documents raised

>safety questions about the SILASTIC II® implant. These documents

>included letters written to Dow Corning by two physicians who

>expressed concern about thickness of the implant's shell and the

>consistency of its silicone gel. Article - THE WALL STREET JOURNAL,

>Feb. 11, 1992

>

>ATTORNEYS SPEAK OUT ABOUT IMPLANT SUIT

>Two lawyers defended the appropriateness of a jury's $7.3 million

>decision against a silicone breast implant manufacturer when they

>spoke at a meeting sponsored by the Breast Implant Information

>Foundation. The attorneys described the verdict as " a punishment for

>fraud and malice by the implant's manufacturer. " Dr.

>

> Miner

>questioned the jury's ability to decide scientific issues and

>suggested that these questions should be reviewed by the National

>Institute of Health. Article - THE ORANGE COUNTY REGISTER, Feb. 8,

>1992

>

>INTERNAL DOW CORNING MEMOS QUESTION BREAST IMPLANT SAFETY

>Dow Corning has released an additional 800 pages of information,

>including inter-office memos, which suggest safety problems with

>silicone breast implants. In one December 13, 1977, memo, a Dow

>Corning employee reported that 52 of 400 implant procedures (done by

>four physicians in Ohio and Michigan) had resulted in ruptures. Dow

>Corning insists that the implants are safe and that these documents

>are not scientific evidence.

>Article - THE DETROIT FREE PRESS, Feb. II, 1992

>

>WOMEN SEEK OTHER OPTIONS FOR BREAST AUGMENTATION & RECONSTRUCTION

>Many women are searching for alternatives to silicone gel implants in

>light of the FDA moratorium. One option is the saline breast which is

>firmer and does not feel as natural as the silicone implant. Another

>

>

>

>

>

>

>

>

>

>

>

>

>

>

><http://promos.hotbar.com/promos/promodll.dll?RunPromo & El= & SG= & RAND=86197 & partn\

er=hbtools>

>Upgrade Your Email - Click here!

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

[Guest guest]

Supposedly Weiss had a heart attack! . . . I wonder though! Rogene